News & Insights

  • 20/03/2018
  • News

Van Bael & Bellis performs exceptionally well in Chambers Europe 2018 with top-tier rankings for its EU competition, international trade and life sciences practices

Van Bael & Bellis has been recognised once again for its exceptional expertise in Chambers Europe 2018, with the following notable results. Three of the firm’s practice areas...

Read more
    • 06/12/2018
    • News

    Andreas Reindl speaks at conference on diversity and inclusion in the legal profession in Brussels

    On 4 December 2018, Van Bael & Bellis senior counsel Andreas Reindl spoke at a conference titled Diversity & Inclusion in the Legal Profession: Exchanging Ideas, Sharing Experiences, and Developing a Strategy for Europe organised by the Institute for Inclusion in the Legal Profession and held in Brussels. Andreas participated in a panel discussion on what law firms in Europe are doing to address diversity and inclusion issues, what particular challenges they face and how they are handling them. Other members of the panel were Harry Small (Baker McKenzie), Etienne Dessy (Linklaters), Vanessa Turner (Allen & Overy) and Kathleen Vercraeye (Past President of the Dutch-speaking Brussels Bar). The panel was moderated by Luisa Menezes (Philip Morris International).

    Read more
    • 05/12/2018
    • News

    Quentin Declève participates in African round table on the reform of investment protection

    On 22 November 2018, Van Bael & Bellis associate Quentin participated in a high level event on the reform of investment protection organized by the Belgian Federal Public Service of Foreign Affairs. The morning session brought together key stakeholders in the reform of the existing Investor State Dispute Settlement (ISDS) mechanisms as well as in the plans for a Multilateral Investment Court (MIC). European Commissioner for Trade, Cecilia Malmström, delivered a keynote speech laying out the EU’s plans for a multilateral investment court. This keynote speech was followed by two presentations: one by Meg Kinnear (Secretary-General of the International Centre for the Settlement of Investment Disputes (ICSID)) and the other by Anna Joubin-Bret (Secretary of the United Nations Commission on International Trade Law (UNCITRAL)). Those presentations were followed by two panel discussions which brought together a broad range of stakeholders, including members of trade unions, the OECD and academia, as well as business and arbitration experts. The afternoon session gathered representatives from several African countries (Angola, Benin, Burkina Faso, South Africa and Zimbabwe) and was aimed at further discussing the ongoing reform and the specific expectations of African countries. During that session, Quentin spoke about the pro bono technical assistance offered by Van Bael & Bellis to the Republic of Benin in the context of ISDS reform. Representatives from the European Commission, the government of the Netherlands and UNCITRAL also took part in the discussion.

    Read more
    • 04/12/2018
    • News

    Porter Elliott quoted by Global Competition Review on the European Commission’s opening of its second Phase II investigation in two days

    Van Bael & Bellis partner Porter Elliott was quoted by Global Competition Review in an article published on 30 November 2018. The article concerned the European Commission’s opening of an in-depth Phase II investigation into Luxembourg-based metal manufacturer Aperam’s proposed acquisition of rival German manufacturer VDM, the second Phase II investigation to be opened in two days and the eighth currently open – four of which are in the metal manufacturing sector. The GCR article is available here.

    Read more
    • 04/12/2018
    • Newsletters

    VBB on Competition Law, Volume 2018, No. 11

    The November 2018 issue of our newsletter, VBB on Competition Law, which covers major developments in competition law at both the European Union and Member State levels.

    Download PDF
    • 03/12/2018
    • News

    Isabelle Van Damme delivers keynote lecture on “International Courts and Tribunals and the Autonomy of the EU Legal Order” at the Annual Meeting of the Netherlands Association for European Law in Amsterdam

    On 30 November 2018, Van Bael & Bellis counsel Isabelle Van Damme spoke on “International Courts and Tribunals and the Autonomy of the EU Legal Order” at the Annual Meeting of the Netherlands Association for European Law in Amsterdam. Isabelle’s keynote lecture focused on the conditions under which the Court of Justice of the European Union accepts that the European Union becomes a party to international agreements providing for a means of dispute settlement, viewed from the perspectives of EU and international law. Further information about the conference is available here.

    Read more
    • 03/12/2018
    • Articles

    Five Further Member State Inspectorates Recognised under EU - US Mutual Recognition System for Medicines

    The Agreement on Mutual Recognition between the European Union and the United States of America continues its roll-out in the realm of pharmaceutical inspections. On two separate occasions in November 2018, the US Food and Drug Administration (“FDA”) added 5 new EU Member States to its list of countries which it considers to have capable inspectorates to carry out good manufacturing practice (“GMP”) inspections at a level equivalent to that observed in the US. These Member States are Belgium, Denmark, Estonia, Finland and Latvia. The updated list of in total 20 Member States whose inspection results the FDA considers can replace its own inspections can be found here: https://www.fda.gov/internationalprograms/agreements/ucm598735.htm. The EU and the US thus seem to be on track to have all EU Member States recognised as capable of carrying out pharmaceutical inspections by 15 July 2019. For its part, the FDA had already been earmarked as a capable inspectorate on 1 November 2017.

    Read more
    • 30/11/2018
    • Articles

    OECD - Pharmaceutical Innovation and Access to Medicines

    The Organisation for Economic Cooperation and Development (“OECD”) has just published a study on Pharmaceutical Innovation and Access to Medicines (the “Study” - available here: Pharmaceutical Innovation and Access to Medicines). The Study forms a response to a request by 35 member countries to prepare a report detailing the challenges for governments in ensuring that their populations have access to novel medicines at a reasonable cost while at the same time maintaining the pharmaceutical sector’s capacity for innovation.

    Read more
    • 28/11/2018
    • News

    VBB Open Office Day 2018

Showing 1-9 of 922 insights

View more
Keep updated Sign up for VBB insights

Be the first amongst your peers to get the latest publications and insights.